Literature DB >> 9924950

Home polysomnography norms for children.

G Stores1, C Crawford, J Selman, L Wiggs.   

Abstract

Home polysomnography (PSG) by means of ambulatory monitoring systems has distinct advantages over sleep laboratory recordings, especially for children. However, normative data have been lacking. Norms for conventional PSG variables were compiled for 60 children age 5-16 years using the Oxford Medilog ambulatory monitoring system. Recordings were confined to a single night in view of previous demonstrations that the sleep on the first night is not significantly affected by the recording procedure. The results are presented in 5 age subgroups. Broad comparisons with published laboratory PSG norms for children of the same ages suggest that in home recordings sleep duration is longer, and slow wave sleep is much more pronounced with a commensurate reduction in stage 2 NREM sleep. That is, sleep quality and quantity appears better at home even when adaptation to the laboratory situation has been promoted. These new normative data are considered valuable for both clinical and research purposes where physiological sleep studies in children are required.

Entities:  

Mesh:

Year:  1998        PMID: 9924950

Source DB:  PubMed          Journal:  Technol Health Care        ISSN: 0928-7329            Impact factor:   1.285


  8 in total

Review 1.  Recognition and management of narcolepsy.

Authors:  G Stores
Journal:  Arch Dis Child       Date:  1999-12       Impact factor: 3.791

2.  The maturational trajectories of NREM and REM sleep durations differ across adolescence on both school-night and extended sleep.

Authors:  Irwin Feinberg; Nicole M Davis; Evan de Bie; Kevin J Grimm; Ian G Campbell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-23       Impact factor: 3.619

3.  Pediatric polysomnography: the patient and family perspective.

Authors:  Shubhadeep Das; Jodi Mindell; Genevieve C Millet; Dafna Ofer; Suzanne E Beck; Thornton B A Mason; Lee J Brooks; Joel Traylor; Carole L Marcus
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

4.  Individuals with Autism Spectrum Disorders Have Equal Success Rate But Require Longer Periods of Systematic Desensitization than Control Patients to Complete Ambulatory Polysomnography.

Authors:  Michelle Primeau; Anda Gershon; Lisa Talbot; Isabelle Cotto; Linda Lotspeich; Antonio Hardan; Joachim Hallmayer; Ruth O'Hara
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

5.  Comparison between reported and recorded total sleep time and sleep latency in 6- to 11-year-old children: the Tucson Children's Assessment of Sleep Apnea Study (TuCASA).

Authors:  James L Goodwin; Graciela E Silva; Kristine L Kaemingk; Duane L Sherrill; Wayne J Morgan; Stuart F Quan
Journal:  Sleep Breath       Date:  2007-06       Impact factor: 2.655

6.  Comparison of home ambulatory type 2 polysomnography with a portable monitoring device and in-laboratory type 1 polysomnography for the diagnosis of obstructive sleep apnea in children.

Authors:  Adelaide Withers; Jennifer Maul; Ellen Rosenheim; Anne O'Donnell; Andrew Wilson; Stephen Stick
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

7.  A school-based health and mindfulness curriculum improves children's objectively measured sleep: a prospective observational cohort study.

Authors:  Christina F Chick; Anisha Singh; Lauren A Anker; Casey Buck; Makoto Kawai; Christine Gould; Isabelle Cotto; Logan Schneider; Omer Linkovski; Rosy Karna; Sophia Pirog; Kai Parker-Fong; Christian R Nolan; Deanna N Shinsky; Priyanka N Hiteshi; Oscar Leyva; Brenda Flores; Ryan Matlow; Travis Bradley; Josh Jordan; Victor Carrion; Ruth O'Hara
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

8.  Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study.

Authors:  Jessica R Lunsford-Avery; Casey Keller; Scott H Kollins; Andrew D Krystal; Leah Jackson; Matthew M Engelhard
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-01       Impact factor: 4.773

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.